Incyte
Price & Volume
Stats
See more52W Range | $56.13-$112.29 |
Market Cap | $19.1B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $5.1B |
Revenue Growth (YoY) | 27.8% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $6.41 |
News
See moreYahoo Finance • 9 days ago
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Yahoo Finance • 12 days ago
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Yahoo Finance • 13 days ago
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
About
CEO | Mr. William J. Meury |
Address | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,844 |
